114 related articles for article (PubMed ID: 19437535)
1. RB1CC1 activates the promoter and expression of RB1 in human cancer.
Ikebuchi K; Chano T; Ochi Y; Tameno H; Shimada T; Hisa Y; Okabe H
Int J Cancer; 2009 Aug; 125(4):861-7. PubMed ID: 19437535
[TBL] [Abstract][Full Text] [Related]
2. RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.
Chano T; Ikebuchi K; Ochi Y; Tameno H; Tomita Y; Jin Y; Inaji H; Ishitobi M; Teramoto K; Nishimura I; Minami K; Inoue H; Isono T; Saitoh M; Shimada T; Hisa Y; Okabe H
PLoS One; 2010 Jun; 5(6):e11404. PubMed ID: 20614030
[TBL] [Abstract][Full Text] [Related]
3. RB1CC1 activates the p16 promoter through the interaction with hSNF5.
Ochi Y; Chano T; Ikebuchi K; Inoue H; Isono T; Arai A; Tameno H; Shimada T; Hisa Y; Okabe H
Oncol Rep; 2011 Oct; 26(4):805-12. PubMed ID: 21637919
[TBL] [Abstract][Full Text] [Related]
4. RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells.
Kontani K; Chano T; Ozaki Y; Tezuka N; Sawai S; Fujino S; Saeki Y; Okabe H
Int J Mol Med; 2003 Nov; 12(5):767-9. PubMed ID: 14533007
[TBL] [Abstract][Full Text] [Related]
5. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells.
Chano T; Ikegawa S; Kontani K; Okabe H; Baldini N; Saeki Y
Oncogene; 2002 Feb; 21(8):1295-8. PubMed ID: 11850849
[TBL] [Abstract][Full Text] [Related]
6. RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients.
Chano T; Ikebuchi K; Tomita Y; Jin Y; Inaji H; Ishitobi M; Teramoto K; Ochi Y; Tameno H; Nishimura I; Minami K; Inoue H; Isono T; Saitoh M; Shimada T; Hisa Y; Okabe H
PLoS One; 2010 Dec; 5(12):e15737. PubMed ID: 21203526
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of RB1CC1 in developing murine and human tissues.
Bamba N; Chano T; Taga T; Ohta S; Takeuchi Y; Okabe H
Int J Mol Med; 2004 Oct; 14(4):583-7. PubMed ID: 15375585
[TBL] [Abstract][Full Text] [Related]
8. Preferential expression of RB1-inducible coiled-coil 1 in terminal differentiated musculoskeletal cells.
Chano T; Saeki Y; Serra M; Matsumoto K; Okabe H
Am J Pathol; 2002 Aug; 161(2):359-64. PubMed ID: 12163359
[TBL] [Abstract][Full Text] [Related]
9. Truncating mutations of RB1CC1 in human breast cancer.
Chano T; Kontani K; Teramoto K; Okabe H; Ikegawa S
Nat Genet; 2002 Jul; 31(3):285-8. PubMed ID: 12068296
[TBL] [Abstract][Full Text] [Related]
10. Activation of aromatase expression by retinoic acid receptor-related orphan receptor (ROR) alpha in breast cancer cells: identification of a novel ROR response element.
Odawara H; Iwasaki T; Horiguchi J; Rokutanda N; Hirooka K; Miyazaki W; Koibuchi Y; Shimokawa N; Iino Y; Takeyoshi I; Koibuchi N
J Biol Chem; 2009 Jun; 284(26):17711-9. PubMed ID: 19439415
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation.
Chano T; Saji M; Inoue H; Minami K; Kobayashi T; Hino O; Okabe H
Int J Mol Med; 2006 Sep; 18(3):425-32. PubMed ID: 16865226
[TBL] [Abstract][Full Text] [Related]
12. Isolation, characterization and mapping of the mouse and human RB1CC1 genes.
Chano T; Ikegawa S; Saito-Ohara F; Inazawa J; Mabuchi A; Saeki Y; Okabe H
Gene; 2002 May; 291(1-2):29-34. PubMed ID: 12095676
[TBL] [Abstract][Full Text] [Related]
13. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
14. Rb1cc1 is critical for myoblast differentiation through Rb1 regulation.
Watanabe R; Chano T; Inoue H; Isono T; Koiwai O; Okabe H
Virchows Arch; 2005 Sep; 447(3):643-8. PubMed ID: 15968549
[TBL] [Abstract][Full Text] [Related]
15. MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
Li S; Qiang Q; Shan H; Shi M; Gan G; Ma F; Chen B
Life Sci; 2016 Feb; 147():143-52. PubMed ID: 26829385
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
Singh J; Murata K; Itahana Y; Desprez PY
Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
[TBL] [Abstract][Full Text] [Related]
17. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
[TBL] [Abstract][Full Text] [Related]
18. p53 regulates FAK expression in human tumor cells.
Golubovskaya VM; Finch R; Kweh F; Massoll NA; Campbell-Thompson M; Wallace MR; Cance WG
Mol Carcinog; 2008 May; 47(5):373-82. PubMed ID: 17999388
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
20. Target specificities of estrogen receptor-related receptors: analysis of binding sequences and identification of Rb1-inducible coiled-coil 1 (Rb1cc1) as a target gene.
Akter MH; Chano T; Okabe H; Yamaguchi T; Hirose F; Osumi T
J Biochem; 2008 Mar; 143(3):395-406. PubMed ID: 18039682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
